Commenters ask FDA to allow rare disease classification for disseminated coccidioidomycosis drugs
Regulatory NewsJeff Craven
GuidancePharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)Regulatory NewsJeff CravenGuidancePharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)